XQ 1H
Alternative Names: XQ-1HLatest Information Update: 07 Oct 2021
At a glance
- Originator Jiangsu Carephar Pharmaceutical
- Class Amines; Lactones; Small molecules; Sulfones; Vascular disorder therapies
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Stroke
Most Recent Events
- 28 Sep 2021 Phase-I clinical trials in Stroke in China (unspecified route) (unspecified route, Injection) before September 2021 (Jiangsu Carephar Pharmaceuticals pipeline, September 2021)
- 28 Sep 2021 Phase-I clinical trials in Stroke in China (unspecified route, Tablet) before September 2021 (Jiangsu Carephar Pharmaceuticals pipeline, September 2021)